Healthcare technology company Syra Health reported a significant increase in revenue from its Population Health unit, with total revenue reaching $2 million in the second quarter of 2024. The company signed contracts with several states, showing growth and diversification in its client base. DarioHealth, a digital therapeutics company, also experienced revenue growth in the second quarter, driven by B2B2C revenues. The company expects to reach cashflow breakeven by the end of 2025, with cost-cutting measures and revenue growth anticipated to reduce operating losses significantly. Both companies are focusing on higher-margin business units and expanding their client base to drive future growth.
Source link
Syra Health reports a 101% increase in revenue in Q2 2024 and more digital health earnings
